Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Germann, P.
Right arrow Articles by Sladen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Germann, P.
Right arrow Articles by Sladen, R.
(Chest. 1998;114:29-35.)
© 1998 American College of Chest Physicians

Addition of Nitric Oxide to Oxygen Improves Cardiopulmonary Function in Patients With Severe COPD

Peter Germann MD1; Rolf Ziesche MD2; Christian Leitner MD1; Georg Roeder MD1; Georg Urak MD1; Michael Zimpfer MD1; and Robert Sladen MD3

1 From the Departments of Anesthesiology and General Intensive Care, University of Vienna, Vienna, Austria
2 From the Department of Pulmonary Medicine, University of Vienna, Vienna, Austria
3 From the Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York

Study objective: To assess the effect of nitric oxide inhalation on pulmonary hemodynamics and oxygenation in patients with COPD receiving long-term oxygen therapy (LTOT).

Design: Prospective study.

Setting: ICU of a university medical center.

Patients: A total of 18 (6 female, 12 male) patients with COPD, spontaneously breathing with LTOT.

Interventions: Oxygenation and hemodynamic variables were measured and calculated at an inspired oxygen fraction (FIO2) adjusted to mimic LTOT conditions (control), and then 1 h after each sequential addition of 5, 10, and 20 ppm nitric oxide to the gas mixture. A newly developed device (Pulmonox) provided both the delivery and continuous analysis of nitric oxide and oxidative nitric oxide products.

Measurements and results: There was a significant improvement in oxygenation at 5 ppm nitric oxide (PaO2/FIO2 ratio improved from 244±37 to 303±59, p<0.05), but no further improvement at higher doses (ceiling effect). There was a dose-dependent improvement in hemodynamic variables that was maximal at 20 ppm nitric oxide (mean pulmonary artery pressure decreased from 29±7 to 24±5 mm Hg, pulmonary vascular resistance index decreased from 565±321 to 392±215 dyne · s · cmminus5 · mminus2, and right ventricular ejection fraction improved from 34±6 to 39±7%, all p<0.05).

Conclusion: Prior studies have demonstrated that inhaled nitric oxide may improve or worsen oxygenation in patients with COPD. Our data show an unequivocal improvement in oxygenation (albeit with a ceiling effect at 5 ppm) and pulmonary hemodynamics (dose dependent) in COPD patients receiving LTOT. Further studies are warranted to examine the usefulness of inhaled nitric oxide during acute exacerbations of COPD, or even the possibility of long-term application in patients receiving LTOT.

Key Words: COPD • long-term oxygen therapy • nitric oxide • pulmonary hypertension

Submitted on July 8, 1997
Accepted on December 2, 1997




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. C. Lanner, M. Raper, W. M. Pratt, and R. A. Rhoades
Heterotrimeric G Proteins and the Platelet-Derived Growth Factor Receptor-{beta} Contribute to Hypoxic Proliferation of Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 412 - 419.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.A. Barbera, V.I. Peinado, and S. Santos
Pulmonary hypertension in chronic obstructive pulmonary disease
Eur. Respir. J., May 1, 2003; 21(5): 892 - 905.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Pepke-Zaba and N W Morrell
Pulmonary hypertension in patients with COPD: NO treatment?
Thorax, April 1, 2003; 58(4): 283 - 284.
[Full Text] [PDF]


Home page
ThoraxHome page
K Vonbank, R Ziesche, T W Higenbottam, L Stiebellehner, V Petkov, P Schenk, P Germann, and L H Block
Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD
Thorax, April 1, 2003; 58(4): 289 - 293.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Sticher, S. Scholz, O. Boning, R. T. Schermuly, C. Schumacher, D. Walmrath, and G. Hempelmann
Small-Dose Nitric Oxide Improves Oxygenation During One-Lung Ventilation: An Experimental Study
Anesth. Analg., December 1, 2002; 95(6): 1557 - 1562.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K. Ashutosh, K. Phadke, J. F. Jackson, and D. Steele
Use of nitric oxide inhalation in chronic obstructive pulmonary disease
Thorax, February 1, 2000; 55(2): 109 - 113.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Das, E. C. Dempsey, D. Bouchey, M. E. Reyland, and K. R. Stenmark
Chronic Hypoxia Induces Exaggerated Growth Responses in Pulmonary Artery Adventitial Fibroblasts . Potential Contribution of Specific Protein Kinase C Isozymes
Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 15 - 25.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Cooper and D. Beasley
Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1326 - H1337.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Chest Physicians.